Blueprint Medicines Receives FDA Approval for AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis (ISM)
Blueprint Medicines Corporation announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT® (avapritinib) for the treatment of adults with Indolent Systemic Mastocytosis (ISM). All U.S. patients with ISM now have access to the first and only approved medicine designed to treat their disease. Systemic Mastocytosis (SM) is a rare hematologic disorder that […]
CIIC ISM Abstract Presented at AAAAI, 2023
CIIC-ISM Scorecard Concept Sheet Abstract text: Development of a Clinical Scoring System to Identify Conditions of Mast Cell Proliferation in a Community Setting Rationale: Indolent systemic mastocytosis (ISM) is primarily driven by the KIT D816V mutation and may cause debilitating symptoms. In the community allergy clinic, defining ISM in the context of other non-clonal mast […]
CIIC APDS Poster Presented at AAAAI, 2023
Title: Approach to Identification of Patients with Activated Phosphoinositide-3 Kinase Delta Syndrome (APDS) Authors: D. Suez 1, R. Wasserman 2, A. Darter 3, E. Perez 4, J. Jacobs 5, D. Siri 6, D. Patterson 7, J. Offenberger 8, W. Lumry 9, M. Scarupa 10 1. Daniel Suez MD, Allergy, Asthma & Immunology Clinic PA, Irving […]
Amerimmune LLC Maintains Intellectual Property on the COVID-19 Related Use of Caspase Inhibitors as a Result of Histogen Inc. Led Arbitration
January 18th, 2023:MCLEAN, Va.–(BUSINESS WIRE)–Amerimmune LLC is a translational medicine biotechnology firm focused on discovery and rapid development of novel therapies for diseases, including COVID-19.Amerimmune LLC had a discovery early in 2020, showing elevated caspase molecules in peripheral blood immune cells of COVID19 patients. Caspase molecules help build immunity to pathogens, but can also have […]
CIIC Welcomes All Infusion Associates Locations as 26th CIIC Member
December 14, 2022 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization comprised of select US Board-Certified Allergists and Immunologists in private practice, is proud to announce the addition of Infusion Associates (https://infusionassociates.com/) as the 26th member of our network. With over 90 healthcare professionals working in 13 locations, Infusion Associates has further […]
CIIC Welcomes 25th Member: Allergy Partners, PLLC
August 23, 2022 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization comprised of select Board-Certified Allergists and Immunologists in private practice throughout the USA, is proud to announce the addition of Allergy Partners, PLLC as its 25th member to the network. Allergy Partners is the nation’s largest single specialty practice with 136 […]
CIIC HAE Posters Presented at the American College of Allergy, Asthma & Immunology Conference
November, 2022, The American College of Allergy, Asthma & Immunology Conference: CIIC Member Dr. Bill Lumry did a great job presenting our first two Hereditary Angioedema (HAE) Posters, that have resulted from the CIIC – Trio Health partnership. Poster Title: Attack Location and Severity/Resolution In Patients With Hereditary Angioedema (HAE); Observations From Community Immunology Abstract […]
Trio Health (Trio) and the Consortium of Independent Immunology Clinics (CIIC) announce the launch of the Trio-CIIC HAE Registry
LOUISVILLE, CO, May 12, 2022 – Enabled by the FDA guidance on the expanded use of real-world data, Trio Health has partnered with the CIIC to create the ‘first of its kind’ HAE (Hereditary Angioedema) Patient Registry. Trio Health’s real-world data platform rapidly converts structured and unstructured EMR data, in real time, including physician notes, […]
Consortium of Independent Immunology Clinics (CIIC) Welcomes Two New Members
Irving, TX / October 21, 2021 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization represented by a group of selected Board-Certified Allergists and Immunologists in private practice throughout the USA, is proud to announce the addition of two new members to its network. The addition of these providers and their clinic […]
Introducing the Creation of a Dynamic Rare Disease Patient Registry Platform
IRVING, TX, September 21, 2021 – Trio Health (Trio), in partnership with the Consortium of Independent Immunology Clinics (CIIC), has launched the creation of a dynamic rare disease patient registry platform to transform drug development for allergy, asthma, and immunology patients. This technology-driven and real-world data-based partnership will unite the power of the […]